-1753360248087.webp&w=3840&q=75)
2025 NOSCM | Innovative Biomarkers and Potential New Pathways in Lung Cancer
Overview
Dr. Fred Hirsch discussed innovative targets and treatments in lung cancer, highlighting HER3, EGFR, SDK11, and KRAS mutations.
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Fred Hirsch, MD, PhD, FASCO
Date of Release
July 24th, 2025
-1755990775594.webp&w=3840&q=75)
-1755990700517.webp&w=3840&q=75)